Importance Schizophrenia is associated with an increased risk of type 2 diabetes. However,
it is not clear whether schizophrenia confers an inherent risk for glucose dysregulation in the …

Background Schizophrenia might share intrinsic inflammatory disease pathways with type 2
diabetes. We aimed to assess whether first-episode psychosis, which could be described as …

Background The extent of metabolic and lipid changes in first-episode psychosis (FEP) is
unclear. Aims To investigate whether individuals with FEP and no or minimal antipsychotic …

Background Dyslipidaemia is one of the most prevalent metabolic disturbances observed in
schizophrenia patients and has been largely attributed to the effects of poor lifestyle habits …

BackgroundIt is unclear what the prevalence of metabolic syndrome (MetS) in drug-naïve
first-episode of psychosis (FEP) is, as previous meta-analyses were conducted in minimally …

Schizophrenia is a debilitating psychiatric illness that remains poorly understood. While the
bulk of symptomatology has classically been associated with disrupted brain functioning …

Background Some studies have suggested that antipsychotic-naïve patients with
nonaffective psychosis (NAP) have glucose intolerance. Aims To conduct a systematic …

Cardiovascular disease in patients with schizophrenia | The Medical Journal of Australia
MJA Basic Search Advanced search search Use the Advanced search for more specific …

For decades, there have been observations demonstrating significant metabolic
disturbances in people with schizophrenia including clinically relevant weight gain …

Rationale Although metabolic abnormalities and metabolic syndrome (MetS) have been
extensively investigated in schizophrenia, few studies have examined them in first-episode …